Table 5.
EQ-5D-3L score | FROM-16 score | EQ-VAS (n=733) | Survivor age (years) | Survivor gender | Survivor hospital stay for COVID-19 | Survivor existing health condition | Number of weeks since COVID-19 diagnosis | Family member | Family member gender | |
EQ-5D-3L score | 1 | |||||||||
FROM-16 score | 0.467** | 1 | ||||||||
EQ-VAS (n=733) | −0.591** | −0.346** | 1 | |||||||
Survivor age (years) | −0.020 | −0.118* | −0.075 | 1 | ||||||
Survivor gender | 0.077* | −0.024 | −0.102* | 0.064 | 1 | |||||
Survivor hospital stay for COVID-19 | 0.127* | 0.073 | −0.097* | 0.143* | −0.091* | 1 | ||||
Survivor existing health condition | 0.093* | 0.066 | −0.104* | 0.201** | 0.036 | 0.134* | 1 | |||
Number of weeks since COVID-19 diagnosis | 0.164* | 0.029 | −0.218 | 0.158* | 0.032 | 0.097* | 0.042 | 1 | ||
Family member age (years) | −0.015 | −0.077 | −0.025 | 0.535** | 0.066 | 0.034 | 0.145* | 0.108* | 1 | |
Family member gender | −0.030 | 0.031 | 0.032 | −0.008 | −0.507** | 0.097* | 0.050 | −0.034 | −0.113* | 1 |
*P≤0.05, **p≤0.01, two-tailed.
†Spearman’s rank.
EQ-5D-3L, EuroQol group five dimensions three level; FROM-16, Family Reported Outcome Measure.